Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Passage BIO, Inc. | 185 776 | déclaré | 27 févr. 2020 | tx 2+219 612 |
| Compass Therapeutics, Inc. | 30 000 | déclaré | 18 févr. 2022 | tx 2+60 000 |
| Chemomab Therapeutics Ltd. | 23 768 | déclaré | 19 avr. 2021 | tx 1+23 768 |
| SpringWorks Therapeutics, Inc. | 15 318 | déclaré | 19 mai 2022 | tx 18+54 423 136−7 152 307 |
| Audentes Therapeutics, Inc. | 9 000 | déclaré | 08 oct. 2017 | tx 2+18 000 |
| ALEXION PHARMACEUTICALS INC | 0 | déclaré | 27 oct. 2014 | tx 284+1 457 400−1 785 017 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 19 mai 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4 818 | 0.00 USD | |
| 19 mai 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 15 318 | 0.00 USD | deriv |
| 18 févr. 2022 | GRANT_AWARD | Compass Therapeutics, Inc. | 30 000 | 0.00 USD | deriv |
| 20 mai 2021 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 1 106 | 0.00 USD | |
| 20 mai 2021 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 6 998 | 0.00 USD | deriv |
| 27 avr. 2021 | SALE | SpringWorks Therapeutics, Inc. | 201 | 75.05 USD | |
| 28 avr. 2021 | SALE | SpringWorks Therapeutics, Inc. | 19 231 | 76.20 USD | |
| 19 avr. 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 23 768 | 0.00 USD | deriv |
| 15 avr. 2021 | SALE | SpringWorks Therapeutics, Inc. | 1 057 | 75.01 USD | |
| 14 avr. 2021 | SALE | SpringWorks Therapeutics, Inc. | 511 | 75.08 USD | |
| 06 août 2020 | GRANT_AWARD | Compass Therapeutics, Inc. | 30 000 | 0.00 USD | deriv |
| 20 mai 2020 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 7 464 | 0.00 USD | deriv |
| 12 mars 2020 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 20 000 | 0.00 USD | deriv |
| 27 févr. 2020 | GRANT_AWARD | Passage BIO, Inc. | 33 836 | 0.00 USD | deriv |
| 27 févr. 2020 | GRANT_AWARD | Passage BIO, Inc. | 185 776 | 0.00 USD | deriv |
| 17 sept. 2019 | PURCHASE | SpringWorks Therapeutics, Inc. | 275 000 | 18.00 USD | |
| 17 sept. 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 1 053 204 | — | |
| 17 sept. 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 6 078 103 | — | |
| 17 sept. 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 1 053 204 | — | deriv |
| 17 sept. 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 6 078 103 | — | deriv |
| 12 sept. 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 29 983 | 0.00 USD | deriv |
| 29 mars 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 40 000 000 | — | deriv |
| 29 mars 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 6 931 142 | — | deriv |
| 08 oct. 2017 | GRANT_AWARD | Audentes Therapeutics, Inc. | 9 000 | 0.00 USD | deriv |
| 24 août 2016 | GRANT_AWARD | Audentes Therapeutics, Inc. | 9 000 | 0.00 USD | deriv |